Learn more about the Alzheimer’s drug lecanemab which just received accelerated approval from the FDA.
Watch Alzheimer’s Orange County CEO, Jim McAleer and CMO of Irvine Clinical Research, Dr. Trinh explain the science behind the new Alzheimer’s drug in this short video chat.
*Video recorded December 2022.